Adolescents and Young Adults (AYAs) With Initially Localized and Metastatic Bone Sarcomas: A Retrospective Single Center Analysis of Side Effect Management

Conclusion: The two studied protocols were well-tolerated in the AYA patients included in this study. Dose reductions instead of dose delays should be considered when side effects occur.

Source: In Vivo - January 5, 2021 Category: Research Authors: MINICHSDORFER, C., STEINBRECHER, O., KÖLZ, M., SCHMID, M., RADERER, M., BRODOWICZ, T., LAMM, W. Tags: Clinical Studies Source Type: research